The GLP is committed to full transparency. Download and review our 2019 Annual Report

Scientists successfully test three different Zika vaccines on monkeys

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The race to develop a safe and effective vaccine against the Zika virus got one step closer [on August 4], when a team of researchers reported positive results in the latest round of testing in monkeys.

The urgency for a vaccine to protect against Zika infection has intensified as the virus spreads rapidly across Latin America and the Caribbean. [Recently,] an unprecedented travel advisory was given for southern Florida after more than a dozen people were diagnosed with Zika after being bitten by “homegrown” mosquitoes.

The results were “striking,” said study coauthor Dr. Dan Barouch, a professor of medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. “The findings published today substantially increase our optimism for the potential for the development of a Zika vaccine for humans.”

Still, with many years of experience in vaccine development behind him, [Dr. Anthony Fauci] said, “you’re never overconfident of the clinical results.”

“But we are optimistic that this new DNA Zika is a viable platform,” Fauci said. “So we’re cautiously optimistic.”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: ‘Striking’ Results from Early Zika Vaccine Trial

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend